SPINELEBIOPHARM SRL
41862631
Company Details
Company name | SPINELEBIOPHARM S.R.L. |
Fiscal Code | 41862631 |
No. Matriculation | J17/1880/2019 |
Foundation date | 06.11.2019 |
You have access to a multitude of information about this company by creating a free account.
Description
Company SPINELEBIOPHARM SRL, Fiscal Code 41862631, was established on 06.11.2019
Contact Information
Address | MELODIEI 18 **** ? |
City / Sector | Galaţi |
County | GALATI |
Country | Romania |
Company indicators (EUR)
Year | CAEN | Business Figure | Net Profit | Debts | Fixed Assets | Current Assets | Own Capitals | Employees (average number) |
---|---|---|---|---|---|---|---|---|
2023 | 7219 | 0 | 0 | 131 | 0 | 40 | -92 | 0 |
2022 | 7219 | 0 | 0 | 131 | 0 | 40 | -92 | 0 |
2021 | 7219 | 0 | 0 | 131 | 0 | 40 | -92 | 0 |
2020 | 7219 | 0 | -620 | 131 | 0 | 40 | -92 | 0 |
2019 | 7219 | 0 | -48 | 131 | 103 | 58 | 30 | 0 |
Business figure vs Profit
Own Capitals
Debts
Frequently Asked Questions
How many employees does company SPINELEBIOPHARM S.R.L. have?
-
In the year 2023 the company SPINELEBIOPHARM SRL had a total of 0 employees
What is the turnover and profit of company SPINELEBIOPHARM S.R.L.?
-
The turnover recorded by SPINELEBIOPHARM S.R.L. in the year 2023 was 0 EUR, and the net profit 0 EUR
Companies with the same CAEN code
Company name | Fiscal Code | No. Matriculation |
---|---|---|
AMBAST CON SRL | 5950559 | J40/18273/1993 |
CASSTIL SA | 795 | J40/214/1991 |
CRIS CASANDRA RT S.R.L. | 43382290 | J12/3923/2020 |
NANOTEHNOLOGII MEDICALE SRL | 33296744 | J40/7291/2014 |
CLINICAL MANAGEMENT S.R.L. | 46598442 | J40/15150/2022 |
AIDAEO S.R.L. | 49011258 | J23/7092/2023 |
Companies from the same locality
Company name | Fiscal Code | No. Matriculation |
---|---|---|
DRIM LOW ALONE SRL | 33461400 | J17/872/2014 |
LIGASTORE ASIG SRL | 33461310 | J17/871/2014 |
RCH CREATIVE WORKS DESIGN SRL | 33461353 | J17/866/2014 |
AUTO PREMIO MAG SRL | 33466490 | J17/876/2014 |
AUTOMAR LOCAL BUSINESS SRL | 33466512 | J17/878/2014 |
DAIANTAX KRP SRL | 33466539 | J17/881/2014 |